NASDAQ NMS - GLOBAL MARKET · AXSM
-1.14% · -$2.37 · Vol 293.2K
Market closed · last close 4:00 PM ET · price as of 16:00:19 ET
Axsome Therapeutics Inc

Axsome Therapeutics Inc

Pharmaceuticals
$205.40
Card
Relationship Map

Veridion Score

BETAHIGH CONF · 6/6 factorsMethodology
AXSM
Axsome Therapeutics Inc
Mon Aug 24 · last completed session · Markets closed · resumes Tue 9:30 ET
SELL BIAS

Composite intelligence score across six company factor categories. Missing inputs are excluded from the active factor subset.

43/ 100
Veridion Score
SELL BIAS · HIGH confidence
Sovereign · $25/mo
See why this score moved.
  • · Factor breakdown with raw signals
  • · Day-over-day delta + driver
  • · Factor coverage readout
  • · Valuation · hype · market flow
  • · Pro Chart event markers
  • · Score history + alerts
Start Sovereign · $25/mo →
Cancel anytime · or Reserve · $79/mo
Confidence: HIGH · 6/6 factors with data · Mon Aug 24 · last completed session · Markets closed · resumes Tue 9:30 ET
Share on X →
Veridion Score History · 90D
Loading score history
AI Analysis
Sovereign

Why is AXSM moving today?

Sovereign unlock connects news, insider activity, analyst moves, and live price action.
Loading AXSM catalysts
About Axsome Therapeutics Inc
PHARMACEUTICAL PREPARATIONS
Listed since
2015
Employees
925
Country
US

Axsome Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel therapies for the management of the central nervous system, or CNS, disorders for which there are limited treatment options. Its pipeline products include AXS-05, AXS-07, AXS-12, and AXS-14. It manages its business as one operating segment and reporting unit, which is the business of developing and delivering novel therapies for the management of CNS disorders.

Company website →
Key statistics

Reported fields plus Veridion-computed history. Unsourced tiles are omitted.

Open
$207.00
Day high
$208.09
Day low
$205.09
Previous close
$207.77
52W high
$255.17
-19.50% from high
52W low
$114.10
65% of range
Market cap
$10.9B
EPS
$-4.1600
Beta
0.62
Shares out
52.4M
Volume
293.2K
0.42× rel vol
Avg volume
694.5K
VWAP
$206.07
Price history computed in-house
1W
-4.77%
1M
-14.77%
3M
-12.42%
1Y
+76.60%
YTD
+12.46%
SMA 50 $231.44 · below
SMA 200 $191.78 · above
52W position 65%

AXSM overview

Veridion Score
43
Registered · 2026-08-24
6 of 6 factors measured
Latest receipt rows
0
No recent disclosure on file.
13F holders
None on file

Related filings and maps

Relationship mapTrace receipt-backed holders and filings around AXSM.Congress trackerSearch the public STOCK Act disclosure ledger.MethodologyReview score inputs, coverage rules, and limitations.
Loading financial statements
Loading AXSM Form 4 filings
Public disclosures

Congress activity in AXSM

Congress trackerOpen ticker disclosure ledger →

No receipt-qualified Congressional disclosure is present for AXSM in the cached public ledger.

Federal contracts

AXSM contract awards, year to date.

Public federal awards linked to this ticker.

Not disclosed
Refresh interval: 12hSource: Federal contract awards
No federal contracts on file for AXSM in this window.
Lobbying spend

AXSM lobbying filings, year to date.

Registered lobbying filings matched to Axsome Therapeutics Inc.

Not disclosed
Refresh interval: 12hSource: LDA disclosure filings
No lobbying filings on file for AXSM in this window.
Loading news for AXSM
Analyst ratings
Sovereign unlock shows live analyst consensus for AXSM.
Options
Sovereign unlock shows live options positioning for AXSM.
Weekly Veridion brief

Rating changes, public disclosure activity, methodology notes, and product updates. One email per week. No advertising list resale.